1. Home
  2. ALTS vs IMAB Comparison

ALTS vs IMAB Comparison

Compare ALTS & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALTS
  • IMAB
  • Stock Information
  • Founded
  • ALTS 1976
  • IMAB 2014
  • Country
  • ALTS United States
  • IMAB United States
  • Employees
  • ALTS N/A
  • IMAB N/A
  • Industry
  • ALTS
  • IMAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALTS
  • IMAB Health Care
  • Exchange
  • ALTS NYSE
  • IMAB Nasdaq
  • Market Cap
  • ALTS 84.1M
  • IMAB 87.2M
  • IPO Year
  • ALTS N/A
  • IMAB 2020
  • Fundamental
  • Price
  • ALTS $5.93
  • IMAB $0.99
  • Analyst Decision
  • ALTS
  • IMAB Strong Buy
  • Analyst Count
  • ALTS 0
  • IMAB 3
  • Target Price
  • ALTS N/A
  • IMAB $8.00
  • AVG Volume (30 Days)
  • ALTS 231.2K
  • IMAB 274.1K
  • Earning Date
  • ALTS 11-12-2024
  • IMAB 03-13-2025
  • Dividend Yield
  • ALTS N/A
  • IMAB N/A
  • EPS Growth
  • ALTS N/A
  • IMAB N/A
  • EPS
  • ALTS N/A
  • IMAB N/A
  • Revenue
  • ALTS $7,110,000.00
  • IMAB $3,313,984.00
  • Revenue This Year
  • ALTS N/A
  • IMAB N/A
  • Revenue Next Year
  • ALTS N/A
  • IMAB N/A
  • P/E Ratio
  • ALTS N/A
  • IMAB N/A
  • Revenue Growth
  • ALTS N/A
  • IMAB N/A
  • 52 Week Low
  • ALTS $0.58
  • IMAB $0.84
  • 52 Week High
  • ALTS $7.09
  • IMAB $2.08
  • Technical
  • Relative Strength Index (RSI)
  • ALTS 56.75
  • IMAB 43.19
  • Support Level
  • ALTS $5.84
  • IMAB $1.03
  • Resistance Level
  • ALTS $6.64
  • IMAB $1.10
  • Average True Range (ATR)
  • ALTS 0.65
  • IMAB 0.06
  • MACD
  • ALTS -0.01
  • IMAB -0.01
  • Stochastic Oscillator
  • ALTS 71.10
  • IMAB 7.58

About ALTS ALT5 SIGMA CORPORATION

ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

Share on Social Networks: